These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7790086)

  • 1. Heterologous antigen expression in Vibrio cholerae vector strains.
    Butterton JR; Beattie DT; Gardel CL; Carroll PA; Hyman T; Killeen KP; Mekalanos JJ; Calderwood SB
    Infect Immun; 1995 Jul; 63(7):2689-96. PubMed ID: 7790086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains.
    Butterton JR; Ryan ET; Acheson DW; Calderwood SB
    Infect Immun; 1997 Jun; 65(6):2127-35. PubMed ID: 9169742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae.
    John M; Crean TI; Calderwood SB; Ryan ET
    Infect Immun; 2000 Mar; 68(3):1171-5. PubMed ID: 10678922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains.
    Butterton JR; Boyko SA; Calderwood SB
    Vaccine; 1993 Oct; 11(13):1327-35. PubMed ID: 8296486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae.
    Ryan ET; Crean TI; Kochi SK; John M; Luciano AA; Killeen KP; Klose KE; Calderwood SB
    Infect Immun; 2000 Jan; 68(1):221-6. PubMed ID: 10603391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.
    Acheson DW; Calderwood SB; Boyko SA; Lincicome LL; Kane AV; Donohue-Rolfe A; Keusch GT
    Infect Immun; 1993 Mar; 61(3):1098-104. PubMed ID: 8432592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
    Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
    Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
    Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
    Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
    Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
    Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
    Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
    Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.
    Michalski J; Galen JE; Fasano A; Kaper JB
    Infect Immun; 1993 Oct; 61(10):4462-8. PubMed ID: 8406837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain.
    Ryan ET; Butterton JR; Smith RN; Carroll PA; Crean TI; Calderwood SB
    Infect Immun; 1997 Jul; 65(7):2941-9. PubMed ID: 9199470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and purification of Shiga-like toxin II B subunits.
    Acheson DW; De Breucker SA; Jacewicz M; Lincicome LL; Donohue-Rolfe A; Kane AV; Keusch GT
    Infect Immun; 1995 Jan; 63(1):301-8. PubMed ID: 7806370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a live, oral, attenuated vaccine against El Tor cholera.
    Taylor DN; Killeen KP; Hack DC; Kenner JR; Coster TS; Beattie DT; Ezzell J; Hyman T; Trofa A; Sjogren MH
    J Infect Dis; 1994 Dec; 170(6):1518-23. PubMed ID: 7995992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies.
    John M; Bridges EA; Miller AO; Calderwood SB; Ryan ET
    Vaccine; 2002 Jun; 20(21-22):2720-6. PubMed ID: 12034098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.